UBS Group AG - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 44 filers reported holding F-STAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$14,0002,224
+4348.0%
0.00%
Q1 2022$0
-100.0%
50
-79.1%
0.00%
Q4 2021$1,000
-66.7%
239
-53.1%
0.00%
Q3 2021$3,000
-62.5%
510
-47.0%
0.00%
Q2 2021$8,000
-11.1%
963
+24.4%
0.00%
Q1 2021$9,000
+800.0%
774
+288.9%
0.00%
Q4 2020$1,0001990.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders